- Home
- COO vs BGB Comparison
COO vs BGB Comparison
Compare COO & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COO
- BGB
- Stock Information
- Founded
- COO 1980
- BGB 2012
- Country
- COO United States
- BGB United States
- Employees
- COO N/A
- BGB N/A
- Industry
- COO Ophthalmic Goods
- BGB Trusts Except Educational Religious and Charitable
- Sector
- COO Health Care
- BGB Finance
- Exchange
- COO Nasdaq
- BGB Nasdaq
- Market Cap
- COO 16.4B
- BGB 538.7M
- IPO Year
- COO N/A
- BGB N/A
- Fundamental
- Price
- COO $74.27
- BGB $12.25
- Analyst Decision
- COO Strong Buy
- BGB
- Analyst Count
- COO 9
- BGB 0
- Target Price
- COO $99.67
- BGB N/A
- AVG Volume (30 Days)
- COO 2.7M
- BGB 154.6K
- Earning Date
- COO 08-27-2025
- BGB 01-01-0001
- Dividend Yield
- COO N/A
- BGB 9.75%
- EPS Growth
- COO 21.77
- BGB N/A
- EPS
- COO 2.07
- BGB N/A
- Revenue
- COO $3,988,200,000.00
- BGB N/A
- Revenue This Year
- COO $6.79
- BGB N/A
- Revenue Next Year
- COO $6.44
- BGB N/A
- P/E Ratio
- COO $35.88
- BGB N/A
- Revenue Growth
- COO 6.88
- BGB N/A
- 52 Week Low
- COO $65.00
- BGB $10.40
- 52 Week High
- COO $112.38
- BGB $11.97
- Technical
- Relative Strength Index (RSI)
- COO 58.09
- BGB 67.83
- Support Level
- COO $69.01
- BGB $12.18
- Resistance Level
- COO $73.80
- BGB $12.33
- Average True Range (ATR)
- COO 1.63
- BGB 0.07
- MACD
- COO 0.83
- BGB 0.02
- Stochastic Oscillator
- COO 91.68
- BGB 85.11
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest
Blackstone Strategic Credit Fund is a closed-end term fund. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.